FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases – The PARLIM trial (AIO KRK 0314) - Modest, DP; Karthaus, M; Kasper, S (Eur J Cancer, 2022)